HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

John Moran Selected Research

EPO protocol

9/2008Facility factors dominate the ability to achieve target haemoglobin levels in haemodialysis patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


John Moran Research Topics

Disease

7Chronic Kidney Failure (Chronic Renal Failure)
08/2014 - 05/2003
4Anemia
06/2009 - 02/2008
3Type 2 Diabetes Mellitus (MODY)
11/2018 - 08/2009
3Type 1 Diabetes Mellitus (Autoimmune Diabetes)
08/2014 - 04/2011
3Hypotension (Low Blood Pressure)
01/2014 - 06/2011
3Cardiovascular Diseases (Cardiovascular Disease)
05/2013 - 11/2003
2Sepsis (Septicemia)
12/2022 - 01/2012
2Diabetes Mellitus
01/2018 - 05/2002
2Infections
01/2012 - 09/2011
2Weight Gain
04/2011 - 10/2007
2Fistula
03/2010 - 01/2002
1Septic Shock (Toxic Shock Syndrome)
12/2022
1Congenital Plasminogen Deficiency
01/2019
1Alstrom Syndrome
11/2018
1Idiopathic Pulmonary Fibrosis
11/2018
1Metabolic Syndrome (Dysmetabolic Syndrome X)
11/2018
1Fibrosis (Cirrhosis)
11/2018
1Charcot-Marie-Tooth Disease (Peroneal Muscular Atrophy)
04/2018
1Atherosclerosis
05/2013
1Bacteremia
01/2012
1Myocardial Stunning (Stunned Myocardium)
06/2011
1Chronic Renal Insufficiency
04/2011
1Peritonitis
03/2010
1Breast Neoplasms (Breast Cancer)
10/2008
1Hyperphosphatemia
09/2008
1Iron Deficiencies
09/2008
1Human Influenza (Influenza)
05/2008
1Gingivitis
01/2007
1Cough
06/2006
1Whooping Cough (Pertussis)
12/2005
1Myocardial Ischemia (Ischemic Heart Diseases)
11/2003
1Hypertension (High Blood Pressure)
06/2003
1Delayed Graft Function
06/2003
1Anuria
05/2002
1Hemolysis
01/2002
1Wounds and Injuries (Trauma)
01/2002
1Arteriovenous Fistula
01/2002

Drug/Important Bio-Agent (IBA)

5SodiumIBA
01/2018 - 04/2011
3SaltsIBA
01/2014 - 04/2011
3IronIBA
06/2009 - 02/2008
2Dietary SodiumIBA
05/2013 - 04/2011
2Serum AlbuminIBA
09/2011 - 05/2002
2AlbuminsIBA
04/2011 - 08/2009
2Hemoglobins (Hemoglobin)IBA
06/2009 - 09/2008
2Proteins (Proteins, Gene)FDA Link
10/2008 - 05/2002
1PlasminogenIBA
01/2019
1setogepramIBA
11/2018
1Myelin P0 Protein (Myelin Protein Zero)IBA
04/2018
1PotassiumIBA
01/2018
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
08/2014
1Biomarkers (Surrogate Marker)IBA
08/2014
1Troponin T (Troponin T1)IBA
01/2014
1AldosteroneIBA
01/2014
1C-Reactive ProteinIBA
01/2014
1Sodium CitrateFDA LinkGeneric
01/2012
1Gentamicins (Gentamicin)FDA LinkGeneric
01/2012
1Heparin (Liquaemin)FDA LinkGeneric
01/2012
1Dialysis SolutionsIBA
04/2011
1Urea (Carbamide)FDA LinkGeneric
02/2009
1MineralsIBA
02/2009
1Multidrug Resistance-Associated Protein 2IBA
10/2008
1ErythropoietinFDA Link
09/2008
1AntigensIBA
05/2008
1Antihypertensive Agents (Antihypertensives)IBA
10/2007
1delmopinolIBA
01/2007
1Pertussis ToxinIBA
06/2006
1AntibodiesIBA
06/2006
1Immunoglobulin G (IgG)IBA
06/2006
1Anti-Infective Agents (Microbicides)IBA
12/2005
1Troponin IIBA
11/2003
1NitrogenIBA
05/2002

Therapy/Procedure

7Renal Dialysis (Hemodialysis)
11/2013 - 01/2002
6Therapeutics
01/2019 - 01/2007
4Catheters
01/2012 - 01/2002
2Home Hemodialysis
10/2007 - 01/2007
1Resuscitation
12/2022
1Critical Care (Surgical Intensive Care)
12/2022
1Transplantation
11/2013
1Renal Replacement Therapy (Therapies, Renal Replacement)
11/2013
1Peritoneal Dialysis
11/2013
1EPO protocol
09/2008
1Kidney Transplantation
06/2003
1Hemofiltration
05/2003